Phenotypical characterization of children with hypersensitivity reactions to NSAIDs

Mathias Cousin, Anca Chiriac, Nicolas Molinari, Pascal Demoly, Davide Caimmi

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Background: Non-steroidal anti-inflammatory drugs (NSAIDs) are the main cause of drug-induced hypersensitivity in children. Many classifications have been proposed, focusing on adults. So far, no large study has deeply investigated a pediatric cohort. The aim of the present study was to describe a population of NSAID hypersensitive patients reporting a reaction during their childhood and to verify whether it is possible to classify pediatric patients, following the EAACI/ENDA classification. Methods: We conducted a historical prospective study including patients evaluated from 1996 to 2015 in the allergy unit of the Montpellier University Hospital. We included 635 patients. For each patient, we recorded clinical manifestations and possible comorbidities and tried to identify possible risk factors. Results: NSAID hypersensitivity was diagnosed in 107 of 635 patients (16.9%). In this group, 43 patients (40.2%) could not be classified following the ENDA recommendations. The main discrepancies were on the patients’ clinical manifestations and on their possible underlying diseases. We identified, on a multivariate analysis, some risk factors for NSAID hypersensitivity: chronic urticaria (OR 7.737, 3.375–18.296 95%CI), atopic status (OR 2.514, 1.504–4.364 95%CI), and allergic rhinoconjunctivitis (OR 1.799, 1.138–2.837 95%CI). On the basis of our results, we are proposing an adapted classification for NSAID hypersensitivity in children. Conclusions: The current ENDA classification does not seem to be adapted for pediatric patients; a modified version does. Our study could help allergists better understand the differences between adults and children in developing hypersensitivity reactions to NSAIDs, but further large-scale prospective longitudinal analyses are required to validate this new classification.

Original languageEnglish
Pages (from-to)743-748
Number of pages6
JournalPediatric Allergy and Immunology
Volume27
Issue number7
DOIs
Publication statusPublished - Nov 1 2016

Fingerprint

Hypersensitivity
Anti-Inflammatory Agents
Drug Hypersensitivity
Pharmaceutical Preparations
Pediatrics
Urticaria
Comorbidity
Multivariate Analysis
Prospective Studies
Population

Keywords

  • children
  • classification
  • drug allergy
  • drug hypersensitivity
  • non-steroidal anti-inflammatory drugs

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Immunology and Allergy
  • Immunology

Cite this

Phenotypical characterization of children with hypersensitivity reactions to NSAIDs. / Cousin, Mathias; Chiriac, Anca; Molinari, Nicolas; Demoly, Pascal; Caimmi, Davide.

In: Pediatric Allergy and Immunology, Vol. 27, No. 7, 01.11.2016, p. 743-748.

Research output: Contribution to journalArticle

Cousin, M, Chiriac, A, Molinari, N, Demoly, P & Caimmi, D 2016, 'Phenotypical characterization of children with hypersensitivity reactions to NSAIDs', Pediatric Allergy and Immunology, vol. 27, no. 7, pp. 743-748. https://doi.org/10.1111/pai.12596
Cousin, Mathias ; Chiriac, Anca ; Molinari, Nicolas ; Demoly, Pascal ; Caimmi, Davide. / Phenotypical characterization of children with hypersensitivity reactions to NSAIDs. In: Pediatric Allergy and Immunology. 2016 ; Vol. 27, No. 7. pp. 743-748.
@article{608b3ccc1194435ab6c945e0bd1d0015,
title = "Phenotypical characterization of children with hypersensitivity reactions to NSAIDs",
abstract = "Background: Non-steroidal anti-inflammatory drugs (NSAIDs) are the main cause of drug-induced hypersensitivity in children. Many classifications have been proposed, focusing on adults. So far, no large study has deeply investigated a pediatric cohort. The aim of the present study was to describe a population of NSAID hypersensitive patients reporting a reaction during their childhood and to verify whether it is possible to classify pediatric patients, following the EAACI/ENDA classification. Methods: We conducted a historical prospective study including patients evaluated from 1996 to 2015 in the allergy unit of the Montpellier University Hospital. We included 635 patients. For each patient, we recorded clinical manifestations and possible comorbidities and tried to identify possible risk factors. Results: NSAID hypersensitivity was diagnosed in 107 of 635 patients (16.9{\%}). In this group, 43 patients (40.2{\%}) could not be classified following the ENDA recommendations. The main discrepancies were on the patients’ clinical manifestations and on their possible underlying diseases. We identified, on a multivariate analysis, some risk factors for NSAID hypersensitivity: chronic urticaria (OR 7.737, 3.375–18.296 95{\%}CI), atopic status (OR 2.514, 1.504–4.364 95{\%}CI), and allergic rhinoconjunctivitis (OR 1.799, 1.138–2.837 95{\%}CI). On the basis of our results, we are proposing an adapted classification for NSAID hypersensitivity in children. Conclusions: The current ENDA classification does not seem to be adapted for pediatric patients; a modified version does. Our study could help allergists better understand the differences between adults and children in developing hypersensitivity reactions to NSAIDs, but further large-scale prospective longitudinal analyses are required to validate this new classification.",
keywords = "children, classification, drug allergy, drug hypersensitivity, non-steroidal anti-inflammatory drugs",
author = "Mathias Cousin and Anca Chiriac and Nicolas Molinari and Pascal Demoly and Davide Caimmi",
year = "2016",
month = "11",
day = "1",
doi = "10.1111/pai.12596",
language = "English",
volume = "27",
pages = "743--748",
journal = "Pediatric Allergy and Immunology",
issn = "0905-6157",
publisher = "Blackwell Munksgaard",
number = "7",

}

TY - JOUR

T1 - Phenotypical characterization of children with hypersensitivity reactions to NSAIDs

AU - Cousin, Mathias

AU - Chiriac, Anca

AU - Molinari, Nicolas

AU - Demoly, Pascal

AU - Caimmi, Davide

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Background: Non-steroidal anti-inflammatory drugs (NSAIDs) are the main cause of drug-induced hypersensitivity in children. Many classifications have been proposed, focusing on adults. So far, no large study has deeply investigated a pediatric cohort. The aim of the present study was to describe a population of NSAID hypersensitive patients reporting a reaction during their childhood and to verify whether it is possible to classify pediatric patients, following the EAACI/ENDA classification. Methods: We conducted a historical prospective study including patients evaluated from 1996 to 2015 in the allergy unit of the Montpellier University Hospital. We included 635 patients. For each patient, we recorded clinical manifestations and possible comorbidities and tried to identify possible risk factors. Results: NSAID hypersensitivity was diagnosed in 107 of 635 patients (16.9%). In this group, 43 patients (40.2%) could not be classified following the ENDA recommendations. The main discrepancies were on the patients’ clinical manifestations and on their possible underlying diseases. We identified, on a multivariate analysis, some risk factors for NSAID hypersensitivity: chronic urticaria (OR 7.737, 3.375–18.296 95%CI), atopic status (OR 2.514, 1.504–4.364 95%CI), and allergic rhinoconjunctivitis (OR 1.799, 1.138–2.837 95%CI). On the basis of our results, we are proposing an adapted classification for NSAID hypersensitivity in children. Conclusions: The current ENDA classification does not seem to be adapted for pediatric patients; a modified version does. Our study could help allergists better understand the differences between adults and children in developing hypersensitivity reactions to NSAIDs, but further large-scale prospective longitudinal analyses are required to validate this new classification.

AB - Background: Non-steroidal anti-inflammatory drugs (NSAIDs) are the main cause of drug-induced hypersensitivity in children. Many classifications have been proposed, focusing on adults. So far, no large study has deeply investigated a pediatric cohort. The aim of the present study was to describe a population of NSAID hypersensitive patients reporting a reaction during their childhood and to verify whether it is possible to classify pediatric patients, following the EAACI/ENDA classification. Methods: We conducted a historical prospective study including patients evaluated from 1996 to 2015 in the allergy unit of the Montpellier University Hospital. We included 635 patients. For each patient, we recorded clinical manifestations and possible comorbidities and tried to identify possible risk factors. Results: NSAID hypersensitivity was diagnosed in 107 of 635 patients (16.9%). In this group, 43 patients (40.2%) could not be classified following the ENDA recommendations. The main discrepancies were on the patients’ clinical manifestations and on their possible underlying diseases. We identified, on a multivariate analysis, some risk factors for NSAID hypersensitivity: chronic urticaria (OR 7.737, 3.375–18.296 95%CI), atopic status (OR 2.514, 1.504–4.364 95%CI), and allergic rhinoconjunctivitis (OR 1.799, 1.138–2.837 95%CI). On the basis of our results, we are proposing an adapted classification for NSAID hypersensitivity in children. Conclusions: The current ENDA classification does not seem to be adapted for pediatric patients; a modified version does. Our study could help allergists better understand the differences between adults and children in developing hypersensitivity reactions to NSAIDs, but further large-scale prospective longitudinal analyses are required to validate this new classification.

KW - children

KW - classification

KW - drug allergy

KW - drug hypersensitivity

KW - non-steroidal anti-inflammatory drugs

UR - http://www.scopus.com/inward/record.url?scp=84991696069&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991696069&partnerID=8YFLogxK

U2 - 10.1111/pai.12596

DO - 10.1111/pai.12596

M3 - Article

AN - SCOPUS:84991696069

VL - 27

SP - 743

EP - 748

JO - Pediatric Allergy and Immunology

JF - Pediatric Allergy and Immunology

SN - 0905-6157

IS - 7

ER -